Impact of recurrent mutations on progression-free survival in CLL patients treated with front line rituximab-based regimens.

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

ŠPUNAROVÁ Michaela MALČÍKOVÁ Jitka TOM Nikola BORSKÝ Marek BRYCHTOVÁ Yvona DOUBEK Michael PANOVSKÁ Anna DIVÍŠKOVÁ Eva MRÁZ Marek POSPÍŠILOVÁ Šárka MAYER Jiří TRBUŠEK Martin

Year of publication 2017
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description Impact of recurrent mutations on progression-free survival in CLL patients treated with front line rituximab-based regimens. Impact of recurrent mutations on progression-free survival in CLL patients treated with front line rituximab-based regimens.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.